Increased Expression of MiR-27a and MiR-24-2 in Esophageal Squamous Cell Carcinoma.
Esophageal squamous cell carcinoma
Gene expression
miR-24-2
miR-27a
microRNA
Journal
Journal of gastrointestinal cancer
ISSN: 1941-6636
Titre abrégé: J Gastrointest Cancer
Pays: United States
ID NLM: 101479627
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
pubmed:
26
4
2019
medline:
11
7
2020
entrez:
26
4
2019
Statut:
ppublish
Résumé
Esophageal squamous cell carcinoma (ESCC) is one of the predominant types of esophageal cancer with poor prognosis which shows high prevalence in eastern countries. Studying microRNAs that were considered for their capabilities such as tissue-specific expression and involvement in different cell features may be informative in the field of diagnostic and prognostic tumor markers. The expression levels of miR-27a and miR-24-2 have been reported to be dysregulated in various cancers and contribute in tumorigenesis and progression; thus, evaluating their expressional behavior and its association with tumor states alteration in ESCC could potentially be helpful. The study was conducted on 30 fresh specimens including tumor and normal counterparts' tissues of ESCC. After the extraction of total RNA, complementary DNA synthesis was performed by the use of linear specific primers. Eventually, real-time polymerase chain reaction was carried out for the measurement of microRNAs expression level. According to the obtained data, miR 27a and miR-24-2 were significantly upregulated (~2.5 fold, p < 0.05) in tumor specimens compared with their normal adjacent tissue; Moreover, upregulation of miR-27a and 24-2 showed cooperative relationship while analyzed. However, there was no correlation between clinicopathological features and microRNAs upregulation. The results of this study show that miR-27a and miR-24-2 cooperatively upregulate in ESCC and suggest that these microRNAs can be introduced as a candidate for further study in the field of screening and prognostic biomarkers.
Identifiants
pubmed: 31020570
doi: 10.1007/s12029-019-00232-x
pii: 10.1007/s12029-019-00232-x
doi:
Substances chimiques
Biomarkers, Tumor
0
MIRN24 microRNA, human
0
MIRN27 microRNA, human
0
MicroRNAs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
227-233Références
J Oral Maxillofac Surg. 2017 Jul;75(7):1449.e1-1449.e8
pubmed: 28413152
Mol Cancer. 2010 Sep 03;9:232
pubmed: 20815877
Mol Cancer. 2017 May 10;16(1):89
pubmed: 28490335
J Biol Chem. 2013 Jun 21;288(25):18121-33
pubmed: 23649631
Biochem Biophys Res Commun. 2016 Jan 1;469(1):55-61
pubmed: 26592661
EMBO Mol Med. 2012 Mar;4(3):143-59
pubmed: 22351564
Oncol Lett. 2013 May;5(5):1639-1642
pubmed: 23761828
Lancet. 2013 Feb 2;381(9864):400-12
pubmed: 23374478
Oral Oncol. 2010 Mar;46(3):204-8
pubmed: 20138800
Oncol Rep. 2015 Aug;34(2):995-1002
pubmed: 26044523
Nat Rev Cancer. 2005 Nov;5(11):845-56
pubmed: 16239904
Oncotarget. 2015 Mar 10;6(7):4920-35
pubmed: 25749032
Clin Biochem. 2017 Apr;50(6):285-292
pubmed: 27939727
Cell Physiol Biochem. 2017;42(5):1920-1933
pubmed: 28772260
Oncol Rep. 2010 Jun;23(6):1625-33
pubmed: 20428818
J Cell Sci. 2013 Mar 15;126(Pt 6):1440-53
pubmed: 23418360
Oncol Rep. 2014 Jan;31(1):280-6
pubmed: 24154848
Neoplasma. 2015;62(2):250-8
pubmed: 25591590
Oncol Lett. 2016 Jun;11(6):4217-4223
pubmed: 27313769
J Cell Biochem. 2014 Mar;115(3):549-56
pubmed: 24122958
Mol Med Rep. 2012 Sep;6(3):459-65
pubmed: 22751839
Cell Physiol Biochem. 2018;46(1):365-374
pubmed: 29590650
Biomed Pharmacother. 2018 May;101:219-227
pubmed: 29494959
Cancer Genet. 2011 Sep;204(9):486-91
pubmed: 22018270
Cancer Lett. 2010 Dec 8;298(2):150-8
pubmed: 20638779
Nucleic Acids Res. 2016 Dec 15;44(22):10603-10618
pubmed: 27625395
Asian Pac J Cancer Prev. 2013;14(1):139-43
pubmed: 23534712
Genet Mol Res. 2016 Dec 19;15(4):
pubmed: 28002594